Acquisition supports Servier's strategic ambition in rare neurology for patients with high unmet medical needs.Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. Transaction represents total value of...

Bitmine owns 4.49% of the total ETH coin supply of 120.7 millionBitmine is 90% of the way to the 'Alchemy of 5%' in just 11 monthsEthereum continues to benefit from...

Bitmine owns 4.49% of the total ETH coin supply of 120.7 million Bitmine is 90% of the way to the 'Alchemy of 5%' in just 11 months Ethereum continues to...

Screens 595 carefully selected genes associated with childhood-onset conditions where early intervention may improve outcomes Designed for maternity hospitals, obstetrics practices, newborn care providers, pediatric clinics and families seeking earlier...

TAIPEI, June 1, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, debuts its 40th anniversary X870E and X870 AORUS INFINITY series motherboards at COMPUTEX 2026. Built for the latest AMD...

>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals.50% extended upper mass range and...

Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows. Identifies up to 40% more lipids...

Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows. Identifies up to 40% more lipids...

TAIPEI, June 1, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, debuts its 40th anniversary X870E and X870 AORUS INFINITY series motherboards at COMPUTEX 2026. Built for the latest AMD...

>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals. 50% extended upper mass range...